Kinghelm Introduces Comprehensive VIS Standardization System for Unified Brand Communication
Mr. Song Shiqiang emphasized that sustainable corporate growth requires strengthened standardization and process management. Kinghelm Electronics and its "Kinghelm" brand are renowned globally in the RF antenna and signal connector industry. To further standardize governance and visual identity, Kinghelm/SLKOR has launched the VIS Standardization System (Version 25.04) in 2025. After 18 years of innovation and market development under Mr. Song's leadership, Kinghelm achieved over 80% growth for three consecutive years (2022–2024). Breakthroughs in R&D, efficient organizational synergy, knowledge engineering, and talent development have driven high-quality growth. The new VIS system unifies brand image, enhances recognition, and boosts competitiveness.
1. C orporate Name: Kinghelm
"Kinghelm" (Helm of the King) embodies the ethos of "inner sagehood, outer kingship." The company adheres to strict quality control, integrity-driven collaboration, and a culture of "integrity, excellence, resilience, and attention to detail." Guided by the principle "Do not impose on others what you do not desire," Kinghelm aims to become a global leader in antennas and connectors, serving the world with cutting-edge technology.
2. Logo
The red-and-white ' Kinghelm® 'logo features dynamic slanted typography, conveying modernity and premium appeal.
3. Slogan
' Kinghelm Connects World ' is handwritten with bold strokes, blending classical calligraphy, street art, and futuristic flair. The slogan aligns precisely with the logo in layout (e.g., the slogan's first character aligns between the "g" and "h" of "Kinghelm"), reflecting the brand's dedication to precision.
4. Brand Avatar & Color Palette
The bilingual avatar uses deep blue as the primary color with red accents—a timeless, eye-catching combination. The 15° upward tilt symbolizes momentum and the team's striving spirit.
5. Business Card
Designed with traditional Chinese motifs (e.g., xiangyun clouds), the card integrates Five Elements theory: blue (wood) background and red (fire) text, signifying "wood fueling fire." A QR code links to Kinghelm's website.
6. PPT Template
Standardized typography and spacing are applied. The template features the English logo and slogan at the top left, a blue base, and a diamond-cut border with the website URL.
7. Document Format
Official documents place the logo in the header (aligned with 15pt font size) and the website/slogan in the footer.
8. Mascot
The blue mascot incorporates antenna elements on its head and ears, symbolizing Kinghelm's core products. Its vibrant smile represents optimism and prosperity.
9. Branded Products
l Promotional Stickers: Red background with cloud patterns and the slogan "Kinghelm connects world."
l Work Uniforms: Worn company-wide, the "vibrant Chinese red" uniforms reflect Kinghelm's culture of perseverance and commitment to China's semiconductor strategy.
l Badminton Jerseys: Worn during team-building sports events to boost cohesion and "core spirit."
10. Promotional Gifts
Gifts (e.g., Bluetooth earphones, power banks, phone stands) feature Kinghelm/SLKOR branding and have been used in campaigns like free umbrella giveaways during rainstorms at Huaqiangbei stores. Branded gift bags and packaging tapes are also standardized under the VIS.
About Kinghelm & SLKOR:
Founded in 2007, Kinghelm (www.kinghelm.net) is a national high-tech enterprise specializing in RF antennas and connectors. It holds multiple patents and certifications (ISO9001, RoHS, REACH).
SLKOR Semiconductor (www.slkoric.com), established in 2015, focuses on advanced materials like SiC MOSFETs and has become synonymous with "domestic substitution." Both companies serve over 20,000 global clients under the leadership of Mr. Song Shiqiang—researcher at the State Council's Economic Development Center and expert in electronics and Huaqiangbei's business ecosystem.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
an hour ago
- CTV News
Tesla deliveries slump, Musk's EV maker stares at second year of falling sales
Tesla posted another big drop in quarterly deliveries on Wednesday, setting it up for its second straight annual sales decline as demand falters due to backlash over CEO Elon Musk's political stance and an aging vehicle lineup. The automaker said it delivered 384,122 vehicles in the second quarter ended June 30, posting a fall of 13.5 per cent from 443,956 units a year ago, despite Musk saying in April that sales had turned around. Still, its shares rose five per cent as the decline was less severe than the bleakest analyst forecast, partly helped by a modest recovery in demand in China. The stock has lost nearly 25 per cent of its value this year. Analysts expected Tesla to deliver 394,378 vehicles, according to an average of 23 estimates from Visible Alpha, although projections dropped as low as 360,080 units based on estimates from 10 analysts over the past month. Several Wall Street brokerages had slashed their deliveries estimates in the past month, fearing demand and brand damage from Musk's embrace of right-wing politics and his role in spearheading the Trump administration's cost-cutting effort. 'The market is reacting to the deliveries not being as bad as potentially thought with multiple analysts cutting their forecasts over the past week,' said Seth Goldstein, senior equity analyst at Morningstar. Tesla in June snapped eight straight months of sales decline in China, a sign that its refreshed Model Y crossover SUV was attracting some buyers despite tough competition from more affordable Chinese rivals such as BYD. Sales also rose in Norway and Spain last month as some buyers turned to the new Model Y in a region where Musk's politics had sent Tesla sales into a free fall. Tough task Still, Tesla faces an uphill task in avoiding another yearly decline. To achieve Musk's target of returning to growth this year, Tesla would need to deliver more than a million units in the usually strong second half - a record, according to analysts. That could be tricky as competition heats up and the Trump administration's massive tax-and-spending bill threatens to eliminate key EV incentives, including a US$7,500 tax credit on new sales and leases. Federal tax credits for EV purchases have helped sustain sales in the sector, even as the U.S. Federal Reserve raised interest rates to tame inflation. Musk and U.S. President Donald Trump have also escalated a feud over the tax bill, with the latter threatening to cut off the billions of dollars in subsidies his companies receive from the federal government. The spat has rattled investors, fueling concerns that regulators could intensify scrutiny of Tesla's self-driving tech that is central to its nearly trillion-dollar valuation. The company last month rolled out a robotaxi service in limited parts of Austin, Texas, for a select group of invitees and with several restrictions, including having a safety monitor in the front passenger seat. The automaker had said it would start producing a cheaper vehicle — expected to be pared-down Model Y by June end. Reuters had reported in April it was delayed by at least a few months. --- Reporting by Akash Sriram in Bengaluru and Abhirup Roy in San Francisco; Editing by Arun Koyyur
Globe and Mail
an hour ago
- Globe and Mail
SKYX Announces 8 Newly Issued U.S. and Global Patents With Now Over 100 Patents and Pending Applications With 45 Issued Patents
SKYX New Patents Were Issued in the U.S., India, Japan, U.K. France, Germany, Italy, and Spain SKYX's Patent Portfolio Includes Advanced Plug & Play Smart Home Platforms, Enabling AI Capabilities and Eco System Integration, Home Safety Sensors, Ceiling Fan & Heater, Lighting, Among Others MIAMI, July 02, 2025 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. (NASDAQ: SKYX) ('SKYX' or the 'Company'), a highly disruptive smart home platform technology company with over 100 issued and pending patents globally and a growing portfolio of over 60 lighting and home décor websites, with a mission to make homes and buildings become smart, safe, and advanced as the new standard, today announces the issuance of 8 newly issued U.S. and global patents with now over 100 patents and pending applications with 45 issued patents. The new patents were issued in U.S., India, Japan, U.K., France, Germany, Italy, and Spain. The Company's patent portfolio includes advanced and plug and play smart home platforms, enabling AI capabilities and ecosystem, home safety sensors, ceiling fan & heater, lighting, among others. SKYX's Total Addressable Market ("TAM") of over $500 billion, with its robust and versatile U.S. and global patent portfolio, creates tremendous Company value. The Company's U.S. and global patent portfolio of over 100 issued and pending patents, 45 of which are issued patents covers SKYX's advanced plug-and-play and smart home platform technologies for safety, smart home, AI, electrical, lighting and ceiling fan industries. Rani Kohen, Founder and Executive Chairman of SKYX Platforms, said: "We are proud to announce these additional 8 patent issuances, which further strengthen our globally robust intellectual property portfolio in the important areas of our advanced safe, smart homes, and sensor technologies. These advancements position SKYX to be a leading technology provider of smart home platforms for the smart home, electrical, lighting and ceiling fan industries.' About SKYX Platforms Corp. As electricity is a standard in every home and building, our mission is to make homes and buildings become safe-advanced and smart as the new standard. SKYX has a series of highly disruptive advanced-safe-smart platform technologies, with over 100 U.S. and global patents and patent pending applications. Additionally, the Company owns over 60 lighting and home decor websites for both retail and commercial segments. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at or follow us on LinkedIn. Forward-Looking Statements Certain statements made in this press release are not based on historical facts, but are forward-looking statements. These statements can be identified by the use of forward-looking terminology such as 'aim,' 'anticipate,' 'believe,' 'can,' 'could,' 'continue,' 'estimate,' 'expect,' 'evaluate,' 'forecast,' 'guidance,' 'intend,' 'likely,' 'may,' 'might,' 'objective,' 'ongoing,' 'outlook,' 'plan,' 'potential,' 'predict,' 'probable,' 'project,' 'seek,' 'should,' 'target' 'view,' 'will,' or 'would,' or the negative thereof or other variations thereon or comparable terminology, although not all forward-looking statements contain these words. These statements reflect the Company's reasonable judgment with respect to future events and are subject to risks, uncertainties and other factors, many of which have outcomes difficult to predict and may be outside our control, that could cause actual results or outcomes to differ materially from those in the forward-looking statements. Such risks and uncertainties include statements relating to the Company's ability to successfully launch, commercialize, develop additional features and achieve market acceptance of its products and technologies and integrate its products and technologies with First-party platforms or technologies; the Company's efforts and ability to drive the adoption of its products and technologies as a standard feature, including their use in homes, hotels, offices and cruise ships; the Company's ability to capture market share; the Company's estimates of its potential addressable market and demand for its products and technologies; the Company's ability to raise additional capital to support its operations as needed, which may not be available on acceptable terms or at all; the Company's ability to continue as a going concern; the Company's ability to execute on any sales and licensing or other strategic opportunities; the possibility that any of the Company's products will become National Electrical Code (NEC)-code or otherwise code mandatory in any jurisdiction, or that any of the Company's current or future products or technologies will be adopted by any state, country, or municipality, within any specific timeframe or at all; risks arising from mergers, acquisitions, joint ventures and other collaborations; the Company's ability to attract and retain key executives and qualified personnel; guidance provided by management, which may differ from the Company's actual operating results; the potential impact of unstable market and economic conditions, including recent measures adopted by the federal government, on the Company's business, financial condition, and stock price; and other risks and uncertainties described in the Company's filings with the Securities and Exchange Commission, including its periodic reports on Form 10-K and Form 10-Q. There can be no assurance as to any of the foregoing matters. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by U.S. federal securities laws. Non-GAAP Financial Measures Management considers earnings (loss) before interest, taxes, depreciation and amortization, or EBITDA, as adjusted, an important indicator in evaluating the Company's business on a consistent basis across various periods. Due to the significance of non-recurring items, EBITDA, as adjusted, enables management to monitor and evaluate the business on a consistent basis. The Company uses EBITDA, as adjusted, as a primary measure, among others, to analyze and evaluate financial and strategic planning decisions regarding future operating investments and potential acquisitions. The Company believes that EBITDA, as adjusted, eliminates items that are not part of the Company's core operations, such as interest expense and amortization expense associated with intangible assets, or items that do not involve a cash outlay, such as share-based payments and non-recurring items, such as transaction costs. EBITDA, as adjusted, should be considered in addition to, rather than as a substitute for, pre-tax income (loss), net income (loss) and cash flows used in operating activities. This non-GAAP financial measure excludes significant expenses that are required by GAAP to be recorded in the Company's financial statements and is subject to inherent limitations. Investors should review the reconciliation of this non-GAAP financial measure to the comparable GAAP financial measure. Investors should not rely on any single financial measure to evaluate the Company's business.
Globe and Mail
an hour ago
- Globe and Mail
Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth?
Johnson & Johnson JNJ, under its Innovative Medicine segment, markets several multi-million-dollar drugs that cover a broad range of areas such as neuroscience, cardiovascular and metabolism, immunology, oncology, pulmonary arterial hypertension (PAH) and infectious diseases. J&J is scheduled to report second-quarter results on July 16 and investors will be keen to know how the Innovative Medicine segment has performed. Here we discuss some key factors that are likely to have affected the segment's sales in the second quarter. J&J's Innovative Medicine unit is showing a growth trend with sales rising in the segment despite the loss of exclusivity (LOE) for its multi-billion-dollar product, Stelara, and the negative impact of the Part D redesign. Higher sales of key products, such as Darzalex, Tremfya and Erleada, due to strong market growth and share gains, are likely to have driven the segment's growth in the second quarter. Sales of some other drugs like Xarelto and Simponi/Simponi Aria are likely to have risen. New drugs like Carvykti, Tecvayli, Talvey, Rybrevant plus Lazcluze and Spravato are also expected to have contributed to growth. However, lower sales of key drugs, Stelara and Imbruvica, and generic/biosimilar competition to drugs like Zytiga and Remicade are likely to have hurt top-line growth. Several biosimilar versions of J&J's multi-billion-dollar immunology drug, Stelara, have been launched in the United States in 2025. According to patent settlements and license agreements, Amgen AMGN, Teva, Samsung Bioepis/Sandoz and some other companies have already launched Stelara biosimilars this year. The Stelara LOE hurt revenue growth by 470 basis points in the first quarter of 2025. We expect the negative impact to be steeper in the second quarter. Rising competitive pressure in the United States due to new oral competition is likely to have hurt sales of Imbruvica. Sales of the PAH drug, Uptravi are likely to have been hurt by the impact of Part D redesign, similar to the first quarter, despite market share gains. However, despite Stelara LOE and Medicare Part D headwinds, J&J expects growth in the Innovative Medicine segment in the second quarter and through the rest of the year. Our estimates for the Innovative Medicine unit suggest a CAGR of around 3% over the next three years. J&J Key Competitors Immunology and oncology are J&J's key areas. Other large drugmakers with a strong presence in the oncology market include Novartis, AstraZeneca AZN, AbbVie ABBV, Merck, Bristol-Myers, Roche and Pfizer. In immunology, AbbVie, Amgen, Sanofi, AstraZeneca and Pfizer hold a strong position. JNJ's Price Performance, Valuation and Estimates J&J's shares have outperformed the industry year to date. The stock has risen 9.6% in the year-to-date period against a 0.6% decline of the industry. From a valuation standpoint, J&J is reasonably priced. Going by the price/earnings ratio, the company's shares currently trade at 14.45 forward earnings, lower than 14.86 for the industry. The stock is also trading below its five-year mean of 15.73. The Zacks Consensus Estimate for 2025 and 2026 earnings has remained unchanged at $10.60 per share and $10.98 per share, respectively, over the past 60 days. J&J has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AstraZeneca PLC (AZN): Free Stock Analysis Report Johnson & Johnson (JNJ): Free Stock Analysis Report Amgen Inc. (AMGN): Free Stock Analysis Report AbbVie Inc. (ABBV): Free Stock Analysis Report
